Lonza News ٤ فبراير ٢٠٢٦ Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Lonza News ٤ فبراير ٢٠٢٦ Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Lonza News ٣٠ يناير ٢٠٢٦ CDMOs dominate the headlines – and Lonza delivers a clear message of strength - European Biotechnology Magazine
Lonza News ٢٩ يناير ٢٠٢٦ Lonza Group Continues To Leverage Biopharma’s Optimization Push (OTCMKTS:LZAGY) - Seeking Alpha
Lonza News ٢٩ يناير ٢٠٢٦ Narrow-Moat Lonza's Long-Term Outlook Driven by Strong Outsourced Drug Manufacturing Demand - Morningstar
Lonza News ٢٩ يناير ٢٠٢٦ Switzerland’s Lonza edges closer to sale of its capsule and health ingredients business - 93.3 The Drive
Endpoints News ٢٨ يناير ٢٠٢٦ Lonza still intends to sell its capsules and health ingredients business
Lonza News ٢٨ يناير ٢٠٢٦ Lonza still intends to sell its capsules and health ingredients business - Endpoints News
Lonza News ٢٨ يناير ٢٠٢٦ Earnings call transcript: Lonza reports strong 2025 results, stock dips - Investing.com
Lonza News ٢٨ يناير ٢٠٢٦ Switzerland's Lonza edges closer to sale of its capsule and health ingredients business - Reuters
Lonza News ٢٨ يناير ٢٠٢٦ Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - Reuters
Lonza News ٢٨ يناير ٢٠٢٦ Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - wkzo.com